GAD2 and Alzheimer disease: The percentage area of GAD65/67 immunoreactivity (Figure 3) did not differ significantly between DLB (0.43 ± 0.008), control (0.43 ± 0.009) and AD (0.23 ± 0.009; Figure 3).